Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes.

Inflammatory bowel diseases - 1 Dec 2013

Safaie Parham, Ham Maggie, Kuang Peter, Mehta Anand S, Wang Mengjun, Cheifetz Adam S, Robson Simon, Lau Daryl, Block Timothy M, Moss Alan C

Abstract excerpt

BACKGROUND: Patients with inflammatory bowel disease have higher proportions of immunoglobulin G (IgG) antibodies lacking N-galactose, also called agalactosyl IgG, in their serum. Such agalactosyl IgGs have been associated with disease activity and the immunogenicity of biologics. The aim was to describe the relationship between circulating levels of a subset of agalactosyl IgGs (anti-α-Gal) and Crohn's disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to C-Reactive Protein
Share to Colitis, Ulcerative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Enzyme-Linked Immunosorbent Assay

Share to Follow-Up Studies

Share to Immunoglobulin G

Share to Lectins

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 24185312
DOI: 10.1097/01.MIB.0000435437.76741.cb
PMCID: PMC4112456

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes.PMID 24185312Read ↗

Lectin-based Immunoassay for Aberrant IgG Glycosylation as the Biomarker for Crohnʼs DiseaseSemantic proximity Read ↗

Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.Semantic proximity Read ↗

Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.Semantic proximity Read ↗

Serologic antiglycan antibodies in inflammatory bowel disease.Semantic proximity Read ↗

The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.Semantic proximity Read ↗

A Multi-Cohort Study of Immunoglobulin G Glycans in Newly Diagnosed Inflammatory Bowel Disease Patients Reveals Accelerated Biological AgingSemantic proximity Read ↗

Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel diseaseSemantic proximity Read ↗

Anti-Glycan Antibodies as Biomarkers for Diagnosis and PrognosisSemantic proximity Read ↗

Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.Semantic proximity Read ↗

Anti-microbial antibodies in celiac disease: trick or treat?Semantic proximity Read ↗

Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives.Semantic proximity Read ↗

Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.